ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 110 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307,060 | -51.8% | 45,967 | -39.5% | 0.00% | -100.0% |
| Q2 2023 | $637,472 | -48.6% | 75,980 | -39.2% | 0.00% | 0.0% |
| Q1 2023 | $1,240,475 | -48.8% | 124,922 | -64.1% | 0.00% | -66.7% |
| Q4 2022 | $2,421,168 | +1.2% | 347,869 | -22.4% | 0.00% | 0.0% |
| Q3 2022 | $2,393,000 | +119.3% | 448,110 | +63.9% | 0.00% | +200.0% |
| Q2 2022 | $1,091,000 | +2.6% | 273,341 | +14.3% | 0.00% | 0.0% |
| Q1 2022 | $1,063,000 | +633.1% | 239,158 | +560.1% | 0.00% | – |
| Q4 2021 | $145,000 | +16.0% | 36,228 | +153.7% | 0.00% | – |
| Q3 2021 | $125,000 | -27.3% | 14,281 | -6.2% | 0.00% | – |
| Q2 2021 | $172,000 | -20.4% | 15,223 | -16.1% | 0.00% | – |
| Q1 2021 | $216,000 | +127.4% | 18,152 | +0.2% | 0.00% | – |
| Q3 2019 | $95,000 | +41.8% | 18,111 | +63.1% | 0.00% | – |
| Q2 2019 | $67,000 | – | 11,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |